Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
46.35%
operating margin TTM
32.59%
revenue TTM
271.52 Million
revenue per share TTM
1.14$
valuation ratios | |
|---|---|
| pe ratio | 21.31 |
| peg ratio | 0.11 |
| price to book ratio | 12.07 |
| price to sales ratio | 9.93 |
| enterprise value multiple | 28.87 |
| price fair value | 12.07 |
profitability ratios | |
|---|---|
| gross profit margin | 51.4% |
| operating profit margin | 32.59% |
| pretax profit margin | 29.48% |
| net profit margin | 46.35% |
| return on assets | 40.45% |
| return on equity | 85.68% |
| return on capital employed | 32.09% |
liquidity ratio | |
|---|---|
| current ratio | 5.97 |
| quick ratio | 2.90 |
| cash ratio | 1.86 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 299.83 |
| operating cycle | 342.62 |
| days of payables outstanding | 35.61 |
| cash conversion cycle | 307.01 |
| receivables turnover | 8.53 |
| payables turnover | 10.25 |
| inventory turnover | 1.22 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.17 |
| debt equity ratio | 0.24 |
| long term debt to capitalization | 0.19 |
| total debt to capitalization | 0.19 |
| interest coverage | 9.98 |
| cash flow to debt ratio | 1.45 |
cash flow ratios | |
|---|---|
| free cash flow per share | 0.47 |
| cash per share | 0.44 |
| operating cash flow per share | 0.50 |
| free cash flow operating cash flow ratio | 0.93 |
| cash flow coverage ratios | 1.45 |
| short term coverage ratios | 97.43 |
| capital expenditure coverage ratio | 14.44 |
Frequently Asked Questions
When was the last time ADMA Biologics, Inc. (NASDAQ:ADMA) reported earnings?
ADMA Biologics, Inc. (ADMA) published its most recent earnings results on 07-11-2024.
What is ADMA Biologics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. ADMA Biologics, Inc. (NASDAQ:ADMA)'s trailing twelve months ROE is 85.68%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. ADMA Biologics, Inc. (ADMA) currently has a ROA of 40.45%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did ADMA's net profit margin stand at?
ADMA reported a profit margin of 46.35% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is ADMA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 5.97 in the most recent quarter. The quick ratio stood at 2.90, with a Debt/Eq ratio of 0.24.